Articlenpj antimicrobials and resistance2026
AMR in wild animals and plants: global trends and future priorities in wildlife-associated antimicrobial resistance research.
Article in npj antimicrobials and resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Antimicrobial resistance (AMR) is a major global health concern, involving complex transmission pathways linking humans, domestic animals, wildlife, and the environment. Wild animals and plants can harbour and transmit AMR, while also serving as sentinels. Here, we aimed to evaluate current knowledge and research gaps on AMR in wild animals and plants to inform One Health research and policy. We conducted a semi‑systematic review of AMR in wild animals and plants, generating a dataset of 866 publications and analysing metadata on host taxa, microbial and genetic targets, and analytical approaches. The literature shows strong taxonomic, geographic, and methodological biases, with mammals and birds dominating, whereas plants (n = 14) and amphibians (n = 10) were rarely studied. Resistant fungi were also under‑represented (2% of studies), while Escherichia spp. accounted for 33% of microbial targets. Employing wildlife‑based surveillance offers a useful policy tool to address key AMR gaps at human-animal-environment interfaces.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.